10 septembre 2019 | International, Naval

Britain’s shipbuilding strategy has not gone according to plan — and industry is noticing

By: Andrew Chuter

LONDON — Confronted with the dilemma of maintaining a naval industrial base after the completion of two 65,000-ton aircraft carriers for the Royal Navy, the British government two years ago launched a national shipbuilding strategy aimed at building an efficient sector, and thus keeping skills and capacity alive.

But the strategy has failed to work out exactly as planned. Two yards closed this year and a third was rescued by nationalization. Meanwhile in the supply chain, the Ministry of Defence had to act quickly on ordering the motor for the Type 26 frigate to prevent the contractor from moving its capabilities to France.

Former shipyard boss Peter Parker, who authored the original shipbuilding strategy, delivered a review of the strategy's status to the MoD, but the update remains under wraps, with no firm timing announced for its publication.

One key element of the strategy included procurement of five general-purpose frigates for the Royal Navy to be competed for by local shipyards in an effort to end BAE Systems' maritime monopoly in Britain. Another included an international competition for up to three 40,000-ton fleet solid support ships. Both programs have subsequently run into stormy waters.

Paul Everitt, the chief executive of ADS, the lobby group that represents British defense, aerospace and security companies, said it's important to continue to support the strategy, even as some of the impetus has been lost.

“We need to stick with the national shipbuilding strategy. It marks a significant shift in the MoD's approach to procurement. The area that has been challenging, though, is that progress has been hindered by the political uncertainty around Brexit and the future size of MoD budgets,” Everitt said, referring to Britain's exit from the European Union.

“Some of the decisions that would help to give industry the longer-term certainty they require to invest or hang in there aren't being made,” he added. “Where do we go next ? It is really about the MoD creating certainty around a pipeline of work from all the key programs, all of which should offer significant amounts of work to U.K. industry over the next 15 years.”

Shipyard survival

Not everyone remains signed up to the shipbuilding strategy, however.

Defense commentator Howard Wheeldon, of Wheeldon Strategic Advisory, is unsure about the relevance of the strategy.

“It's no longer fit for purpose. We have moved on. More shipyards have closed due to lack of work, and we should not kid ourselves that a commercial shipyard that has little or no expertise in building Navy ships can take on the responsibility and risk that the government requires,” Wheeldon said.

“If the government has any belief in the strategy, it will ensure that contracts for the fleet [solid] support ships will be placed in U.K. shipyards. If it fails, then we must conclude that it has neither belief in its own strategy or in ensuring that we retain the sovereign capability that a nation such as the U.K. needs,” he added.

An international competition to build two or three fleet solid support ships has been underway for months, with the bidders narrowed down to Navantia of Spain, Japan Marine United Corp., and a homemade consortium made up of BAE Systems, Babcock International, Cammell Laird and Rolls-Royce, known as Team UK.

The MoD opened the deal to foreign bidders, reasoning that the vessels were not warships and therefore, under European Union regulations, the competition must be open to all.

Now, though, the tide seems to be turning in favor of British yards taking a bigger share of the work than just the fitting of locally made sensitive kit.

One senior industry executive, who spoke on condition of anonymity, said the “current fleet solid support [ship] procurement plan is not really tenable with the current government team and a shipbuilding strategy which is in danger of becoming unstitched.”

“The government will have come under huge pressure on this issue at every political level. You have a new procurement minister, [Marie-Anne Trevelyn], who only a couple of months ago put her name to a parliamentary report supporting building the ships in the U.K.; you have a Brexiter defense secretary in Ben Wallace; and [Prime Minister Boris] Johnson himself,” the industry executive said. “Is that trio likely to award a contract to a Spanish yard?”

Whatever the outcome, it's too late for two of the yards. Babcock's Appledore yard in southwest England closed in early 2019 after the completion of an offshore patrol boat for the Irish Naval Service. Additionally, Harland & Wolff recently went into insolvency proceedings with its Belfast, Northern Ireland, yard that famously built the Titanic — although there remains a chance a buyer could be found for the facility.

In Glasgow, shipbuilder Ferguson's nationalization by the Scottish government was announced Aug. 16 after the yard went over time and over budget with a commercial ferry contract it won.

Harland & Wolff was the lead U.K. yard in a proposal by German-based Atlas Elektronik to build Type 31e frigates for the Royal Navy. The yard's demise could scuttle the German company's bid, although parent company Thyssenkrupp has a history of reviving cold yards.

Atlas isn't the only company with Harland & Wolff on its team. Babcock also listed the Northern Ireland yard in its Type 31e proposal at one stage and also named Ferguson as a subcontractor.

Britain has shortlisted three contenders for the Type 31e requirement: Atlas, Babcock and BAE Systems. A decision on a winner is expected this year, although there has been speculation it could come during or soon after the DSEI trade show in September.

Second-order effects

The supply chain has not been immune from difficulties either.

GE Power, which provides power-conversion systems for Royal Navy warships, announced it was closing its Rugby site in Central England and relocating the work to France. In response, the MoD ordered motors for a second batch of Type 26s to prevent the move, even though BAE does not yet have a deal to build the warships.

The industry executive said the GE Power episode highlighted a weakness in Britain's shipbuilding strategy.

“GE proved the point: It [the strategy] didn't really address the criticality of the supply chain. It assumed the criticality was all about shipyards,” he said. “The other fundamental flaw with it was you were never going to keep all the U.K. yards in business if you were going to put the fleet solid support ship deal offshore.”

The situation certainly isn't improved by the political turmoil at the MoD and in wider government.

Defense and procurement leaders have been coming and going with alarming regularity for years , particularly since the government adopted the shipbuilding strategy in September 2017.

Penny Mordaunt, the pro-Navy, pro-buy-British defense secretary, lasted just more than 60 days before she found herself backing the wrong candidate in a Conservative Party leadership contest, which resulted in Johnson becoming prime minister on July 24.

Given the current political uncertainties, there is no guarantee how long the new administration will last.

With the Brexit debate occupying the government nearly 24/7, defense has barely rated a mention by the Johnson government; that is, other than during the furor caused by the Royal Navy's inability to stop the seizure of a British-registered tanker by Iran on July 19.

The uncertainties have come at a time of mixed fortunes for the British maritime sector.

Yards may be closing, but set against that is the Type 26 anti-submarine frigate design scoring major export successes in Australia and Canada — successes that could put Britain back on the maritime export map in a big way.

Neither of the export customers will have their frigates built in the U.K., but the deals open the door to potentially billions of pounds of orders for the British supply chain.

https://www.defensenews.com/global/europe/2019/09/08/britains-shipbuilding-strategy-has-not-gone-according-to-plan-and-industry-is-noticing/

Sur le même sujet

  • Should the military treat the electromagnetic spectrum as its own domain?

    7 novembre 2019 | International, Aérospatial, Naval, Terrestre, C4ISR, Sécurité

    Should the military treat the electromagnetic spectrum as its own domain?

    By: Nathan Strout Military leaders are reluctant to treat the electromagnetic spectrum as a separate domain of warfare as they do with air, land, sea, space and cyber, even as the service increasingly recognize the importance of superiority in this area. At the Association of Old Crows conference Oct. 30, representatives from the Army, Navy and Air Force weighed in on a lingering debate: whether the electromagnetic spectrum should be considered its own domain. In short, while the spectrum can legitimately be described as a physically distinct domain, it does not make sense logistically for the Department of Defense to declare it a separate domain of warfare, they said. “It's something that we've had a lot of discussion about ... In one way, you can argue that the physical nature of the electromagnetic spectrum, the physical nature of it being a domain. However, I understand the implications and those are different challenges for a large organization like the Department of Defense. So I think that there's a little bit of a different discussion when you talk about domain and what that implies for the Department of Defense and each of the departments in a different way,” said Brig. Gen. David Gaedecke, director of electromagnetic spectrum superiority for the Air Force's deputy chief of staff for strategy, integration and requirements. Regardless of whether it's an independent domain, military leaders made clear that leveraging the electromagnetic spectrum is a priority for every department and every platform. “We're going to operate from strategic down to tactical, and EMS ... is going to enable all of our forces to communicate and maneuver effectively, so we'll have a layered approach across all the domains that we operate in,” said Laurence Mixon from the Army's Program Executive Office for Intelligence, Electronic Warfare and Sensors. “EMS is definitely an aspect of the operational environment that every tactician has to be aware of, understand and leverage. And on the acquisition side we have to consider EMS when we are developing every one of our systems. I think since EMS crosses all of the domains that we currently have today that we identify and use in the joint parlance--I don't think the Army is ready to call it a domain." Similarly, while the Navy is working to understand how EMS works best within the maritime domain, Rear Adm. Steve Parode, director of the Navy's Warfare Integration Directorate, N2/N6F, indicated that there was no rush to declare EMS a separate domain. “For the Navy, we're pretty comfortable with the way we are into the maritime domain as our principal operational sphere. We are working through understanding the EMS and the way it relates to physical properties in that domain. We know where we're strong and we know where we're weak. And we understand principally why we're weak. We're making decisions about how to get better,” said Parode. https://www.c4isrnet.com/electronic-warfare/2019/11/06/should-the-military-treat-the-electromagnetic-spectrum-as-its-own-domain/

  • A New Layer of Medical Preparedness to Combat Emerging Infectious Disease

    25 février 2019 | International, Autre défense

    A New Layer of Medical Preparedness to Combat Emerging Infectious Disease

    DARPA has selected five teams of researchers to support PREventing EMerging Pathogenic Threats (PREEMPT), a 3.5-year program first announced in January 2018 to reinforce traditional medical preparedness by containing viral infectious diseases in animal reservoirs and insect vectors before they can threaten humans. Through studies in secure laboratories and simulated natural environments, the PREEMPT researchers will model how viruses might evolve within animal populations, and assess the safety and efficacy of potential interventions. Autonomous Therapeutics, Inc., Institut Pasteur, Montana State University, The Pirbright Institute, and the University of California, Davis, lead the PREEMPT teams. “DARPA challenges the PREEMPT research community to look far left on the emerging threat timeline and identify opportunities to contain viruses before they ever endanger humans,” said Dr. Brad Ringeisen, the DARPA program manager for PREEMPT. “One of the chief limitations of how infectious disease modeling is currently conducted is that it forecasts the trajectory of an outbreak only after it is underway in people. The best that data can do is inform a public health response, which places the United States in a reactive mode. We require proactive options to keep our troops and the homeland safe from emerging infectious disease threats.” According to the World Health Organization (WHO), approximately 60 percent of emerging infectious diseases reported globally are zoonoses, meaning that they were initially diseases of animals and at some point became capable of infecting people. Zoonotic diseases are responsible for millions of human deaths every year, and the scope of the challenge is increasing due to the densification of livestock production, human encroachment into natural spaces, and upward trends in globalization, temperature, and population. Ebola is a high-profile example of a zoonotic disease. Despite being relatively difficult to spread — requiring direct contact with fluids from infected organisms — a string of outbreaks over the past five years has highlighted the threat it could present once established in densely populated areas. Researchers express even greater concern over the pandemic potential of new strains of the influenza virus and other airborne pathogens. Even in the United States and its territories, where viruses do not frequently emerge directly from animal reservoirs, vector-borne transmission of zoonoses such as West Nile virus disease is on the rise. The 2018 U.S. National Biodefense Strategy directs that it is essential to detect and contain such bio-threats, adopting a proactive posture to improve preparedness while also assessing and managing any biosecurity risks related to possible interventions. “The health of the American people depends on our ability to stem infectious disease outbreaks at their source, wherever and however they occur,” the document states. For the Department of Defense, that obligation extends to protection of deployed service members, who often operate in countries that are “hot spots” for emerging viruses yet lack robust public health infrastructure. The teams DARPA selected for PREEMPT comprise multidisciplinary researchers who bring expertise and field experience from around the world, some of whom represent institutions from nations at high risk from emerging infectious disease. Institutions participating as sub-contractors to DARPA receive funding from the lead organizations except as otherwise noted. The PREEMPT teams proposed to model specific diseases to assess the risk of spillover from animals into humans, identify key bottlenecks in the process as opportunities for intervention, and develop and assess novel, animal- or insect-focused interventions with built-in safety switches to prevent cross-species jump. The teams will collect samples from animal reservoirs in the field for analysis in secure, bio-contained facilities; some teams will also conduct analysis on existing banked samples and datasets. DARPA is not funding the release of PREEMPT interventions into the environment. Autonomous Therapeutics, Inc., under principal investigator Dr. Ariel Weinberger, leads a team made up of CSIRO Australian Animal Health Laboratory; Navy Medical Research Unit-2, funded directly by DARPA; University of California, Los Angeles; University of Chicago Medical School; and University of Texas Medical Branch. The team will study air-borne highly pathogenic avian influenza virus in birds and small mammals, and tick-borne Crimean-Congo hemorrhagic fever virus. The Center for Comparative Medicine and the One Health Institute at the University of California, Davis, under principal investigator Dr. Peter Barry and co-PI Dr. Brian Bird, respectively, lead a team made up of the Leibniz Institute for Experimental Virology; Mount Sinai School of Medicine; Rocky Mountain Laboratories of the National Institutes of Health (NIH), to be funded directly by DARPA; The Vaccine Group, Ltd., a spin-out of University of Plymouth; University of Glasgow; University of Idaho; and University of Western Australia. The team will examine Lassa virus spillover from rodents, and study Ebola virus in rhesus macaques. The Institut Pasteur, under principal investigator Dr. Carla Saleh, leads a team made up of Institut Pasteur International Network partners in Cambodia, Central African Republic, France, French Guiana, Madagascar, and Uruguay; Latham BioPharm Group; and Virginia Polytechnic Institute and State University. The team will study several mosquito-borne arboviruses, which refers broadly to animal or human viruses transmitted by insects, as well as mosquito-specific viruses that could interfere with arbovirus infection in the insect vector. Montana State University, under principal investigator Dr. Raina Plowright, leads a team made up of the Cary Institute of Ecosystem Studies; Colorado State University; Cornell University; Griffith University; Johns Hopkins University; NIH's Rocky Mountain Laboratories, funded directly by DARPA; Pennsylvania State University; Texas Tech University; University of California, Berkeley; University of California, Los Angeles; and University of Cambridge. The team will study henipavirus spillover from bats. The henipavirus genus of viruses contains multiple biothreat agents as categorized by NIH and the Centers for Disease Control and Prevention (CDC). The Pirbright Institute, under principal investigator Dr. Luke Alphey, leads a team made up of the University of Nottingham and the University of Tartu. The team seeks to disrupt mosquito transmission of flaviviruses, which include Dengue fever, West Nile, and Zika viruses. Modeling and quantification are as important as new experimental technologies in preventing cross-species jumps. The results from modeling will inform when, where, and at what levels such interventions could be applied to achieve the greatest health benefits. Interventions under consideration include animal- or insect-targeted vaccines, therapeutic interfering particles, gene editors, and indirect approaches informed by environmental and ecological factors that affect how viruses are spread — for instance, understanding the environmental stressors that drive bats into closer contact with humans and devising mitigating options to reduce the likelihood of that contact. The research teams' approaches each come with a unique set of potential benefits and challenges, and the teams are responsible for assessing and demonstrating to DARPA the safety, efficacy, stability, and controllability of their proposed interventions. In the future, these considerations could factor into decisions by the ultimate end users — communities, governments, and regulators — on which strategies to pursue to prevent new zoonoses. DARPA and the PREEMPT teams receive guidance from independent expert advisors in the ethical, legal, social, and regulatory aspects of the life sciences. These individuals include Dr. Claudia Emerson, director of the Institute on Ethics & Policy for Innovation at McMaster University; Dr. Matt Kasper, legislative liaison for the U.S. Navy's Bureau of Medicine and Surgery, and a former deputy director of field laboratory operations at the Naval Medical Research Center; and Dr. Steve Monroe, associate director for Laboratory Science and Safety at the CDC, and a former deputy director of the CDC's National Center for Emerging and Zoonotic Infectious Diseases. The teams also benefit from established relationships with local universities, communities, and governments based on prior or ongoing research. These relationships will facilitate initial field collection and help to familiarize stakeholders with PREEMPT technologies as they are being developed. DARPA is also beginning outreach to the WHO as a potential avenue for future transition of PREEMPT technologies. DARPA intends that PREEMPT teams will perform fundamental research and publish results for review by the broader scientific community. https://www.darpa.mil/news-events/2019-02-19

  • Ukrainian army revamps commercial drones to attack Russian tanks, trenches

    16 mai 2023 | International, Aérospatial

    Ukrainian army revamps commercial drones to attack Russian tanks, trenches

    A former IT programmer now serving as a Ukrainian soldier says a four-rotor commercial drone which sells over the counter for $300 can be modified to carry explosives that will destroy Russian tanks.

Toutes les nouvelles